Avacta Group PLC (AVCT) - Net Assets

Latest as of June 2025: GBX144.00K GBX ≈ $17.52 USD

Based on the latest financial reports, Avacta Group PLC (AVCT) has net assets worth GBX144.00K GBX (≈ $17.52 USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX29.24 Million ≈ $3.56K USD) and total liabilities (GBX29.09 Million ≈ $3.54K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Avacta Group PLC balance sheet assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX144.00K
% of Total Assets 0.49%
Annual Growth Rate N/A
5-Year Change -85.01%
10-Year Change -51.49%
Growth Volatility 4068.73

Avacta Group PLC - Net Assets Trend (2001–2024)

This chart illustrates how Avacta Group PLC's net assets have evolved over time, based on quarterly financial data. Check Avacta Group PLC (AVCT) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Avacta Group PLC (2001–2024)

The table below shows the annual net assets of Avacta Group PLC from 2001 to 2024. For live valuation and market cap data, see Avacta Group PLC market cap and net worth.

Year Net Assets Change
2024-12-31 GBX9.28 Million
≈ $1.13K		 -57.44%
2023-12-31 GBX21.80 Million
≈ $2.65K		 +18.26%
2022-12-31 GBX18.44 Million
≈ $2.24K		 -55.27%
2021-12-31 GBX41.22 Million
≈ $5.02K		 -33.44%
2020-12-31 GBX61.93 Million
≈ $7.53K		 +139.95%
2019-12-31 GBX25.81 Million
≈ $3.14K		 +20.53%
2018-07-31 GBX21.41 Million
≈ $2.61K		 -28.36%
2017-07-31 GBX29.89 Million
≈ $3.64K		 -16.64%
2016-07-31 GBX35.86 Million
≈ $4.36K		 +87.41%
2015-07-31 GBX19.13 Million
≈ $2.33K		 -33.65%
2014-07-31 GBX28.84 Million
≈ $3.51K		 +85.42%
2013-07-31 GBX15.55 Million
≈ $1.89K		 -8.28%
2012-07-31 GBX16.96 Million
≈ $2.06K		 +48.27%
2011-07-31 GBX11.44 Million
≈ $1.39K		 +14.70%
2010-07-31 GBX9.97 Million
≈ $1.21K		 +20.16%
2009-07-31 GBX8.30 Million
≈ $1.01K		 +70.40%
2008-07-31 GBX4.87 Million
≈ $592.42		 +85.20%
2007-07-31 GBX2.63 Million
≈ $319.87		 +18678.57%
2006-04-30 GBX14.00K
≈ $1.70		 -33.33%
2005-04-30 GBX21.00K
≈ $2.56		 -97.97%
2004-04-30 GBX1.03 Million
≈ $125.81		 +549.57%
2003-04-30 GBX-230.00K
≈ $-27.98		 +56.52%
2002-04-30 GBX-529.00K
≈ $-64.36		 -45.73%
2001-04-30 GBX-363.00K
≈ $-44.17		 --

Equity Component Analysis

This analysis shows how different components contribute to Avacta Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 13837600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX36.94 Million 398.03%
Other Comprehensive Income GBX-2.04 Million -22.01%
Other Components GBX113.21 Million 1219.83%
Total Equity GBX9.28 Million 100.00%

Avacta Group PLC Competitors by Market Cap

The table below lists competitors of Avacta Group PLC ranked by their market capitalization.

Company Market Cap
M3 Mining Ltd
AU:M3M
 $3.55 Million
Activate Energy Acquisition Corp. Warrant
NASDAQ:AEAQW
 $3.55 Million
Franchise Brands PLC
LSE:FRAN
 $3.55 Million
BELLUSCURA PLC LS -01
F:9VQ
 $3.55 Million
Eneco Refresh Ltd
AU:ERG
 $3.54 Million
Cipta Selera Murni Pt
JK:CSMI
 $3.54 Million
Noroo Holdings Co Ltd
KO:000325
 $3.54 Million
Smart Equity AG
HM:SE3
 $3.54 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Avacta Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 21,805,000 to 9,281,000, a change of -12,524,000 (-57.4%).
  • Net loss of 52,841,000 reduced equity.
  • New share issuances of 31,876,000 increased equity.
  • Other comprehensive income decreased equity by 364,999.
  • Other factors increased equity by 8,805,999.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX-52.84 Million -569.35%
Share Issuances GBX31.88 Million +343.45%
Other Comprehensive Income GBX-365.00K -3.93%
Other Changes GBX8.81 Million +94.88%
Total Change GBX- -57.44%

Book Value vs Market Value Analysis

This analysis compares Avacta Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2342.30x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-04-30 GBX-0.05 GBX66.50 x
2002-04-30 GBX-0.08 GBX66.50 x
2003-04-30 GBX-0.03 GBX66.50 x
2004-04-30 GBX0.15 GBX66.50 x
2005-04-30 GBX0.00 GBX66.50 x
2006-04-30 GBX0.00 GBX66.50 x
2007-07-31 GBX0.38 GBX66.50 x
2008-07-31 GBX0.61 GBX66.50 x
2009-07-31 GBX0.87 GBX66.50 x
2010-07-31 GBX0.79 GBX66.50 x
2011-07-31 GBX0.74 GBX66.50 x
2012-07-31 GBX0.68 GBX66.50 x
2013-07-31 GBX0.49 GBX66.50 x
2014-07-31 GBX0.69 GBX66.50 x
2015-07-31 GBX0.38 GBX66.50 x
2016-07-31 GBX0.53 GBX66.50 x
2017-07-31 GBX0.44 GBX66.50 x
2018-07-31 GBX0.33 GBX66.50 x
2020-12-31 GBX0.27 GBX66.50 x
2021-12-31 GBX0.17 GBX66.50 x
2022-12-31 GBX0.07 GBX66.50 x
2023-12-31 GBX0.08 GBX66.50 x
2024-12-31 GBX0.03 GBX66.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Avacta Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -569.35%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -46761.95%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 5.20x
  • Recent ROE (-569.35%) is below the historical average (-317.69%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 0.00% -1666.67% 0.04x 0.00x GBX-113.70K
2002 0.00% -1509.09% 0.06x 0.00x GBX-113.10K
2003 0.00% 0.00% 0.00x 0.00x GBX-88.00K
2004 -28.82% -1568.42% 0.01x 1.34x GBX-401.40K
2005 -5252.38% -352.40% 1.46x 10.24x GBX-1.11 Million
2006 -764.29% -2675.00% 0.12x 2.36x GBX-108.40K
2007 -46.37% -575.00% 0.07x 1.08x GBX-1.48 Million
2008 -30.16% -315.11% 0.09x 1.06x GBX-1.96 Million
2009 -32.36% -284.43% 0.10x 1.09x GBX-3.51 Million
2010 -18.85% -90.90% 0.18x 1.13x GBX-2.88 Million
2011 -5.17% -24.17% 0.20x 1.08x GBX-1.73 Million
2012 -6.52% -35.34% 0.17x 1.09x GBX-2.80 Million
2013 -9.78% -56.33% 0.15x 1.14x GBX-3.08 Million
2014 -5.17% -46.92% 0.10x 1.08x GBX-4.38 Million
2015 -52.99% -559.24% 0.08x 1.12x GBX-12.05 Million
2016 -12.96% -214.64% 0.06x 1.05x GBX-8.23 Million
2017 -21.30% -232.80% 0.09x 1.06x GBX-9.36 Million
2018 -41.23% -319.54% 0.12x 1.10x GBX-10.97 Million
2020 -30.50% -881.11% 0.03x 1.09x GBX-25.08 Million
2021 -63.84% -894.80% 0.06x 1.14x GBX-30.44 Million
2022 -200.35% -382.68% 0.10x 5.02x GBX-38.78 Million
2023 -114.41% -875.03% 0.04x 3.36x GBX-27.13 Million
2024 -569.35% -46761.95% 0.00x 5.20x GBX-53.77 Million

Industry Comparison

This section compares Avacta Group PLC's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $3,316,891
  • Average return on equity (ROE) among peers: -131.36%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Avacta Group PLC (AVCT) GBX144.00K 0.00% 202.03x $3.54 Million
4BASEBIO UK SOCIETAS (4BB) $-492.00K 0.00% 0.00x $989.13K
Aptamer Group PLC (APTA) $899.87K -50.56% 0.55x $155.87K
Arecor Therapeutics PLC (AREC) $670.33K -166.97% 2.08x $280.23K
BSF Enterprise Plc (BSFA) $4.86 Million -30.89% 0.08x $13.28K
Bioventix (BVXP) $2.68 Million 33.03% 0.07x $959.93K
Cizzle Biotechnology Holdings PLC (CIZ) $32.00K -956.25% 1.81x $89.22K
Amur Minerals Corporation (CRTX) $23.13 Million -10.58% 0.03x $59.80K
Fusion Antibodies PLC (FAB) $-73.00K 0.00% 0.00x $134.83K
Faron Pharmaceuticals Oy (FARN) $-1.85 Million 0.00% 0.00x $582.06K

About Avacta Group PLC

LSE:AVCT UK Biotechnology
Market Cap
$3.54 Million
GBX29.10 Billion GBX
Market Cap Rank
#29155 Global
#550 in UK
Share Price
GBX66.50
Change (1 day)
-2.06%
52-Week Range
GBX43.25 - GBX89.00
All Time High
GBX274.91
Categories
Companies in UK Biotechnology
About

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatec… Read more